The current valuation score of Greenwich Lifesciences Inc is 9.00, ranking 64 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -14.97, which is -64.32% below the recent high of -5.34 and -129.29% above the recent low of -34.33.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.